Medtronic plc logo
Medtronic plc (MDT)
Compare

Medtronic plc (MDT) Stock Price: $81.98+1.29 (+1.60%)

The total return cagr for Medtronic plc (MDT) stock is -3.29% over the past 12 months. The 3 year average growth rate is 2.58% and the 5 year cagr is -4.95%. Total return includes dividends reinvested.

The closing share price for Medtronic plc (MDT) stock was $81.98 for Tuesday, June 9, 2026, up +1.60% from the previous day.

MDT Price Chart

End-of-day pricesAdvanced chart →
MDT$81.98 -4.86%as of Jun 9, 2026

MDT Earnings Preview

Next Earnings Date

Aug 18, 2026

70 days away

EPS Estimate

1.39

Revenue Est.

$9.56B

Last Quarter Results

EPS

$1.55

vs Estimate

$1.54

Met

Revenue

$9.81B

vs Estimate

$9.62B

Beat

MDT Analyst Ratings

Consensus Rating

Buy

Based on 26 analysts

Strong Buy
3
Buy
15
Hold
12
Sell
0
Strong Sell
0

Average Price Target

$98.58

+20.2% upside

Low

$78.00

Current

$81.98

High

$121.00

MDT Analyst Estimates

Forward P/E: 12.84

Earnings Per Share (EPS) Estimates

Quarterly

PeriodLowAvgHigh# Analysts
Q3 2026N/A$1.39N/A16
Q4 2026N/A$1.35N/A16
Q1 2027N/A$1.43N/A11
Q2 2027N/A$1.78N/A7

Annual

PeriodLowAvgHigh# Analysts
FY 2028N/A$6.39N/A15
FY 2029N/A$6.95N/A4

Revenue Estimates

Quarterly

PeriodLowAvgHigh# Analysts
Q3 2026N/A$9.56BN/A16
Q4 2026N/A$9.49BN/A16
Q1 2027N/A$9.56BN/A11
Q2 2027N/A$10.31BN/A7

Annual

PeriodLowAvgHigh# Analysts
FY 2028N/A$39.98BN/A15
FY 2029N/A$41.64BN/A4

Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.

MDT Competitors' Key Metrics

StockMarket CapClose PricePrice ChangeTTM Total Return5Y CAGR10Y CAGR
1MDT$105.25B$81.98+1.60%-3.29%-4.95%+2.19%

About Medtronic plc

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

Galway
95,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Geoffrey Straub Martha